These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7083126

  • 1. Neutrophil-mediated tumor cell destruction in cancer ascites.
    Katano M, Torisu M.
    Cancer; 1982 Jul 01; 50(1):62-8. PubMed ID: 7083126
    [Abstract] [Full Text] [Related]

  • 2. New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction.
    Katano M, Torisu M.
    Surgery; 1983 Mar 01; 93(3):365-73. PubMed ID: 6600854
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
    Katano M, Yamamoto H, Mizoguchi T, Hidaka K, Hisatsugu T, Torisu M.
    Gan To Kagaku Ryoho; 1987 Aug 01; 14(8):2464-8. PubMed ID: 3497612
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Intraperitoneal cavity injection of OK-432 with fresh human serum in a case of carcinomatous peritonitis--determination on the complement-derived chemotactic factor].
    Kato H, Kondo Y, Tanigawa M, Kin R, Sugino S, Kondo M.
    Gan To Kagaku Ryoho; 1986 Oct 01; 13(11):3251-5. PubMed ID: 3777961
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of intraperitoneal administration of OK-432 for patients with advanced cancer.
    Toge T, Yamada H, Aratani K, Kameda A, Kuroi K, Hisamatsu K, Hattori T.
    Jpn J Surg; 1985 Jul 01; 15(4):260-5. PubMed ID: 2932585
    [Abstract] [Full Text] [Related]

  • 11. Advanced ovarian cancer treated by intraperitoneal immunotherapy with OK-432.
    Kawagoe K, Masuda H.
    Jpn J Clin Oncol; 1986 Jun 01; 16(2):137-42. PubMed ID: 3735703
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.
    Mori H, Itoh N, Tamaya T.
    Immunopharmacol Immunotoxicol; 1989 Jun 01; 11(1):33-53. PubMed ID: 2503555
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Antitumor activity of neutrophils induced by a nonspecific immunopotentiator OK-432. II. Experimental study using human malignant ascites].
    Umemoto T, Saji S, Oonishi A, Kunii Y, Goshima H, Tachibana S, Takao H, Tanemura H, Sakata K.
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul 20; 23(7):1512-7. PubMed ID: 3183459
    [No Abstract] [Full Text] [Related]

  • 19. Induction of endogenous cytokines in ascites of patients with ovarian cancer by OK-432, a streptococcal preparation.
    Mori H, Itoh N, Yamada Y, Tamaya T.
    Asia Oceania J Obstet Gynaecol; 1989 Sep 20; 15(3):281-9. PubMed ID: 2512905
    [Abstract] [Full Text] [Related]

  • 20. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
    Yamaguchi Y, Satoh Y, Miyahara E, Noma K, Funakoshi M, Takashima I, Sawamura A, Toge T.
    Anticancer Res; 1995 Sep 20; 15(5B):2201-6. PubMed ID: 8572625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.